Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-05 08:32 |
Pharming Group reports financial results for the first half of 2021
|
English | 95.8 KB | ||
| 2021-08-04 23:27 | English | 287.4 KB | |||
| 2021-07-20 08:19 |
Pharming signs agreement with NewBridge Pharmaceuticals for the commercializati…
|
English | 22.4 KB | ||
| 2021-07-01 08:35 |
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and C…
|
English | 27.2 KB | ||
| 2021-06-23 08:25 |
Pharming announces completion of enrolment in Phase II/III study with leniolisi…
|
English | 229.4 KB | ||
| 2021-06-18 08:22 |
Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as C…
|
English | 147.1 KB | ||
| 2021-06-04 08:14 |
Pharming Group N.V. announces the reimbursement of RUCONEST® in Spain
|
English | 138.2 KB | ||
| 2021-06-01 08:24 |
Pharming Group to present at Jefferies Virtual Healthcare Conference
|
English | 133.2 KB | ||
| 2021-05-20 08:40 |
Pharming Reports on Annual General Meeting of Shareholders
|
English | 24.8 KB | ||
| 2021-05-17 07:55 |
Pharming celebrates the 10th annual "hae day :-)"
|
English | 175.1 KB | ||
| 2021-05-14 08:16 |
Pharming Group reports financial results for the first quarter of 2021
|
English | 179.2 KB | ||
| 2021-04-22 08:38 |
Pharming announces enrolment of first patient in multicentre Phase IIb clinical…
|
English | 250.5 KB | ||
| 2021-04-08 08:38 |
Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with…
|
English | 374.0 KB | ||
| 2021-04-07 08:34 |
Pharming Group announces the publication of its 2020 Annual Report and convenes…
|
English | 375.4 KB | ||
| 2021-04-06 23:35 | English | 8.8 MB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
